Glenmark Pharmaceuticals announced that its Monroe, North Carolina manufacturing plant received a Form 483 with five observations from the ...

The risk-to-reward ratio is unfavourable at current levels. Earnings downgrades will continue due to a lack of new launches.

The Associated Press found more than 3,600 shipments of wood, metals, rubber and other goods have arrived at U.S. ports from Russia since i...

"The OAI classification implies inter‐alia that the USFDA may withhold approval of any pending product applications or supplements filed fr...

The US Food and Drug Administration has provided its first supplemental Abbreviated New Drug Application approval for the company's plant i...

The proposed facility would house three units to produce oral solids, injectables and topicals and begin production by the end of the curre...